Serious issues relating to the clinical use of unlicensed botulinum toxin products.
Pickett
Andy
A
Mewies
Martin
M
D001905:Botulinum Toxins / Q000009:adverse effects / Q000592:standards*; D002681:China; D004348:Drug Labeling; D006801:Humans
D001905:Botulinum Toxins